Abstract
Doxorubicin is a chemotherapy drug used to treat several types of cancer, with high effectiveness, but can cause toxicity in several organs, limiting its use. Toxicity to peripheral muscles is multifactorial and not well stablished, but doxorubicin appears to alter muscle energy metabolism, leading to an increase in anaerobic metabolism. Loss of muscle mass is a prognostic marker in these…